
December 5, 2023
Use of GLP-1 Receptor Agonists to Treat Substance and Alcohol Use Disorders is Promising, but Premature
Christian Hendershot, PhD, associate professor of psychiatry and director of the Clinical and Translational Addiction Research Program at the UNC School of Medicine, co-wrote a commentary on repurposing the antidiabetic medication semaglutide to treat substance and alcohol use disorders.